Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Cancer Medicine|February 12, 2014
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancerIkuo Wada, Hirokazu Matsushita, Shuichi Noji, et al.
Surgery Today|June 11, 2017
Results of a nationwide questionnaire-based survey on nutrition management following gastric cancer resection in JapanNobuyuki Shimizu, Fumihiko Hatao, Kazuhiko Fukatsu, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 28, 2021
Renal Dysfunction is the Strongest Prognostic Factor After Carotid Artery Stenting According to Real-World DataShigeta Miyake, Ryosuke Suzuki, Taisuke Akimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2005
The mechanism of in-stent restenosis in radius stent: an experimental porcine studyYoshitaka Iso, Hiroshi Suzuki, Takatoshi Sato, et al.
The Journal of Biological Chemistry|April 5, 2005
Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cellsHiroki Sugita, Masaki Fujimoto, Takashi Yasukawa, et al.
International Journal of Cardiology|June 1, 2005
Rho-kinase inhibitor suppressed restenosis in porcine coronary balloon angioplastyYoshitaka Iso, Hiroshi Suzuki, Takatoshi Sato, et al.
No Shinkei Geka. Neurological Surgery|May 9, 2014
[A case of glioblastoma multiforme in the pineal region with intraventricular hemorrhage]Ryotaro Suzuki, Kensuke Suzuki, Yoshiki Sugiura, et al.
The Journal of Biological Chemistry|June 25, 2011
Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3betaToshihiro Tanioka, Yoshiaki Tamura, Makiko Fukaya, et al.
No Shinkei Geka. Neurological Surgery|July 28, 2018
[Efficacy and Safety of Salvage ESHAP Chemotherapy for Recurrent/Refractory PCNSLs]Kagemichi Nagao, Taishi Nakamura, Kensuke Tateishi, et al.
Development (Cambridge, England)|August 12, 2016
Epb41l5 competes with Delta as a substrate for Mib1 to coordinate specification and differentiation of neuronsMiho Matsuda, Kinneret Rand, Greg Palardy, et al.
Pageof 13